PIPA5116696

CD52 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA5116696-Each-of-1 In Stock ₹ 46,502.50

PIPA5116696 - Each of 1

₹ 46,502.50

In Stock

Quantity

1

Base Price: ₹ 46,502.50

GST (18%): ₹ 8,370.45

Total Price: ₹ 54,872.95

Antigen

CD52

Classification

Polyclonal

Conjugate

Unconjugated

Gene

CD52

Gene Alias

AI463198; B7; B7-Ag; cambridge pathology 1 antigen; CAMPATH-1; CAMPATH-1 antigen; Cd52; CD52 antigen; CD52 antigen (CAMPATH-1 antigen); CD52 molecule; CDW52; CDW52 antigen (CAMPATH-1 antigen); CLS1; Epididymal secretory protein E5; epididymis secretory sperm binding protein Li 171mP; he5; HEL-S-171mP; human epididymis-specific protein 5; Lymphocyte differentiation antigen B7; Mb7

Host Species

Rabbit

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

1043, 23833

Content And Storage

-20° C, Avoid Freeze/Thaw Cycles

Form

Liquid

Applications

Immunohistochemistry (Paraffin), Western Blot

Concentration

0.42 mg/mL

Formulation

PBS with 50% glycerol and 0.05% ProClin 300; pH 7.3

Gene Accession No.

P31358, Q64389

Gene Symbols

CD52

Immunogen

A synthetic peptide corresponding to a sequence within amino acids 1-61 of human CD52 (NP_0017942)

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human, Mouse

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA5117009

--

Img

Thermo Scientific

PIPA5116538

--

Img

Thermo Scientific

PIPA5116883

--

Img

Thermo Scientific

PIPA5116827

--

Img

Thermo Scientific

PIPA5117052

--

Img

Thermo Scientific

PIPA5114456

--

Img

Thermo Scientific

PIPA5116830

--

Img

Thermo Scientific

PIPA5114521

--

Description

  • Positive Samples: Mouse bone marrow Immunogen sequence: GQNDTSQTSS PSASSNI CD52, also known as CAMPATH-1 antigen, is a glycoprotein that is expressed on the surface of various immune cells, including T and B lymphocytes, natural killer cells, and monocytes
  • It is involved in the regulation of immune responses and is being studied as a potential therapeutic target in various diseases, including multiple sclerosis, chronic lymphocytic leukemia, and autoimmune disorders
  • CD52 is the target of alemtuzumab, a monoclonal antibody that is used to treat these conditions by depleting immune cells that express CD52.